Written by Sophie Renaud MD, Frank Jackson DO Severe hemorrhage remains one of the most life-threatening complications after miscarriage and abortion, yet treatment options beyond uterotonics and hysterectomy are limited. The Jada device is currently the only approved vacuum device for uterine hemorrhage, but it was only studied for use in immediate postpartum hemorrhage in…
Written by Marissa Ghant MD, Mark Pearlman MD, Justine Wu MD, MPH Annually, 1 in 6 new breast cancer (BC) diagnoses occur in reproductive-aged individuals.1 Those at risk for unplanned pregnancy should receive contraceptive counseling. Per the Society of Family Planning/Society of Gynecologic Oncology Guidelines2 non-hormonal methods should be first line methods, emergency contraception (including levonorgestrel-containing)…
Written by C. Peony Khoo, MD, IBCLC Nearly 60% of abortions in the U.S. reported in 2022 were among people who had had at least one prior live birth.1 Given this high proportion of parents seeking abortion, a subset of these people may be nursing. Furthermore, certain contraceptive methods, such as fertility awareness, may be…
Clinicians, advocates, and health systems can utilize this toolkit when integrating medication abortion care into their practices. It covers building buy-in, administrative and operational logistics, how to prepare staff, clinical workflow and patient education, navigating federal restrictions on abortion, and sustainability. Each chapter contains links to resources and a worksheet that can be completed to help…